TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Over the last 12 months, insiders at TherapeuticsMD, Inc. have bought $0 and sold $43,684 worth of TherapeuticsMD, Inc. stock.
On average, over the past 5 years, insiders at TherapeuticsMD, Inc. have bought $7.38M and sold $7.95M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 14,825 shares for transaction amount of $90,284 was made by Rubric Capital Management LP (director) on 2022‑12‑09.
2023-12-07 | Sale | Walker Marlan D | Chief Executive Officer | 4,550 0.0421% | $2.24 | $10,187 | -1.12% | |
2023-12-06 | Sale | Walker Marlan D | Chief Executive Officer | 14,500 0.1412% | $2.31 | $33,496 | -0.45% | |
2023-04-26 | Sale | Walker Marlan D | Chief Executive Officer | 692 0.0079% | $3.64 | $2,518 | -25.21% | |
2023-04-12 | Sale | Walker Marlan D | Chief Executive Officer | 1,170 0.013% | $3.65 | $4,276 | -23.69% | |
2023-01-27 | Sale | Donegan Michael C | Prin. Fin. and Acctg. Officer | 49 0.0005% | $5.09 | $249 | -30.90% | |
2023-01-26 | Sale | Donegan Michael C | Prin. Fin. and Acctg. Officer | 1,648 0.0183% | $5.08 | $8,371 | -27.36% | |
2023-01-24 | Sale | Donegan Michael C | Prin. Fin. and Acctg. Officer | 7 <0.0001% | $5.31 | $37 | -29.48% | |
2023-01-23 | Sale | Donegan Michael C | Prin. Fin. and Acctg. Officer | 1,302 0.0145% | $5.34 | $6,950 | -30.45% | |
2022-12-30 | Sale | Rubric Capital Management LP | director | 29,000 – | $1,333.00 | $38.66M | -31.84% | |
2022-12-09 | Sale | Bernick Brian | Co-Chief Executive Officer | 320 0.0035% | $6.31 | $2,020 | -39.72% | |
2022-12-09 | Rubric Capital Management LP | director | 14,825 0.1558% | $6.09 | $90,284 | -39.72% | ||
2022-12-08 | Rubric Capital Management LP | director | 300 0.0032% | $5.83 | $1,749 | -35.20% | ||
2022-12-07 | Sale | Naughton Gail K | director | 3,922 0.038% | $5.26 | $20,635 | -35.44% | |
2022-12-07 | Rubric Capital Management LP | director | 20,113 0.2099% | $5.66 | $113,890 | -35.44% | ||
2022-12-06 | Sale | Walker Marlan D | General Counsel | 1,048 0.0106% | $4.95 | $5,185 | -28.06% | |
2022-12-06 | Sale | Donegan Michael C | Interim CFO/CAO/VP of Finance | 910 0.0089% | $4.78 | $4,345 | -28.06% | |
2022-12-06 | Sale | Bernick Brian | Co-Chief Executive Officer | 935 0.0094% | $4.92 | $4,602 | -28.06% | |
2022-12-06 | Sale | Glickman Mark A | Co-Chief Executive Officer | 440 0.0044% | $4.92 | $2,165 | -28.06% | |
2022-10-28 | Rubric Capital Management LP | director | 7,000 – | $1,000.00 | $7M | -32.38% | ||
2022-09-30 | Rosen David Efraim | 7,000 – | $1,000.00 | $7M | -37.05% |
Walker Marlan D | Chief Executive Officer | 62565 0.5916% | $1.72 | 0 | 6 | |
Finizio Robert G | CEO | 17991637 170.1305% | $1.72 | 5 | 24 | <0.0001% |
Collins Cooper C. | director | 2236864 21.152% | $1.72 | 7 | 1 | <0.0001% |
Milligan John C.K. IV | Secretary/CEO of subsidiary | 1752703 16.5737% | $1.72 | 3 | 24 | <0.0001% |
Thompson Tommy G | director | 715600 6.7668% | $1.72 | 13 | 0 | <0.0001% |
C.S. Finance LLC | 357606 3.3816% | $1.72 | 1 | 0 | ||
JENSEN GERALD L | President | 258878 2.448% | $1.72 | 26 | 0 | |
SEGAL NICHOLAS | director | 215485 2.0376% | $1.72 | 1 | 1 | +111.31% |
BISARO PAUL | director | 196864 1.8616% | $1.72 | 2 | 0 | <0.0001% |
Ling Karen | director | 130309 1.2322% | $1.72 | 1 | 0 | <0.0001% |
DArecca James | Chief Financial Officer | 123830 1.1709% | $1.72 | 0 | 1 | |
Russell Angus C. | director | 93500 0.8841% | $1.72 | 5 | 0 | <0.0001% |
BORKOWSKI EDWARD | EVP, Operations | 59248 0.5603% | $1.72 | 0 | 1 | |
Cartwright Daniel A | CFO | 40000 0.3782% | $1.72 | 0 | 4 | |
Rosen David Efraim | 22000 0.208% | $1.72 | 3 | 0 | <0.0001% | |
MANDEL RICHARD H JR | director | 13100 0.1239% | $1.72 | 4 | 2 | |
Donegan Michael C | Prin. Fin. and Acctg. Officer | 11853 0.1121% | $1.72 | 0 | 7 | |
CARROLL J MARTIN | director | 10000 0.0946% | $1.72 | 1 | 0 | +16.97% |
LaPenta Robert V Jr | director | 10000 0.0946% | $1.72 | 1 | 0 | +22.11% |
MUSING JULES A. | director | 5000 0.0473% | $1.72 | 2 | 1 | +112.05% |
Bernick Brian | Co-Chief Executive Officer | 3872 0.0366% | $1.72 | 2 | 24 | <0.0001% |
Barlow Jane F | director | 3144 0.0297% | $1.72 | 1 | 0 | <0.0001% |
Glickman Mark A | Co-Chief Executive Officer | 1294 0.0122% | $1.72 | 0 | 1 | |
JENSEN JULIAN D | director | 0 0% | $1.72 | 0 | 3 | |
Naughton Gail K | director | 0 0% | $1.72 | 0 | 1 | |
Krassan Mitchell | Chief Strategy Officer | 0 0% | $1.72 | 0 | 6 | |
SARUBBI KIMBERLY | 0 0% | $1.72 | 0 | 1 | ||
Tjon Robin Natalie | 0 0% | $1.72 | 0 | 1 | ||
Jensen Development CO | Former President | 0 0% | $1.72 | 0 | 2 | |
MASTROPIETRO DONALD R | 0 0% | $1.72 | 0 | 1 | ||
Rubric Capital Management LP | director | 0 0% | $1.72 | 4 | 1 | <0.0001% |
Helm Capital Management LLC | $2.73M | 10.34 | 1.19M | 0% | +$0 | 0.08 | |
Clearline Capital LP | $1.23M | 4.64 | 535,340 | +14.83% | +$158,305.46 | 0.12 | |
Tejara Capital Ltd | $920,436.00 | 3.49 | 401,937 | 0% | +$0 | 0.31 | |
The Vanguard Group | $887,563.00 | 3.36 | 387,582 | 0% | +$0 | <0.0001 | |
BlackRock | $310,934.00 | 1.18 | 135,779 | -0.35% | -$1,108.36 | <0.0001 | |
Morgan Stanley | $301,575.00 | 1.14 | 131,692 | -0.06% | -$171.75 | <0.0001 | |
Geode Capital Management | $194,220.00 | 0.74 | 84,788 | 0% | +$0 | <0.0001 | |
Bridgeway Capital Management | $89,539.00 | 0.34 | 39,100 | -6.91% | -$6,641.00 | <0.01 | |
State Street | $68,929.00 | 0.26 | 30,100 | 0% | +$0 | <0.0001 | |
Clear Harbor Asset Management | $59,103.00 | 0.22 | 25,809 | New | +$59,103.00 | 0.01 | |
The Prosperity Consulting Group, LLC | $56,105.00 | 0.21 | 24,500 | New | +$56,105.00 | 0.01 | |
Ameriprise Financial | $51,456.00 | 0.2 | 22,470 | -0.04% | -$20.61 | <0.0001 | |
Northern Trust | $37,687.00 | 0.14 | 16,457 | -0.21% | -$77.86 | <0.0001 | |
Renaissance Technologies | $31,000.00 | 0.12 | 13,700 | New | +$31,000.00 | <0.0001 | |
J. Goldman & Company | $31,057.00 | 0.12 | 13,562 | 0% | +$0 | <0.01 | |
Gabelli Funds Llc | $27,480.00 | 0.1 | 12,000 | -58.62% | -$38,930.00 | <0.0001 | |
Dimensional Fund Advisors | $23,253.00 | 0.09 | 10,154 | 0% | +$0 | <0.0001 | |
Fidelity Investments | $18,982.00 | 0.07 | 8,289 | 0% | +$0 | <0.0001 | |
UBS | $17,894.00 | 0.07 | 7,814 | +514.31% | +$14,981.13 | <0.0001 | |
Citadel Advisors LLC | $11,363.00 | 0.04 | 4,962 | New | +$11,363.00 | <0.0001 | |
Tower Research Capital | $3,749.00 | 0.01 | 1,637 | +14,781.82% | +$3,723.81 | <0.0001 | |
Banque Cantonale Vaudoise | $2,000.00 | 0.01 | 1,000 | 0% | +$0 | <0.0001 | |
Advisor Group Holdings Inc | $2,371.00 | 0.01 | 1,036 | +2,777.78% | +$2,288.61 | <0.0001 | |
National Bank Of Canada Fi | $1,447.00 | 0.01 | 720 | 0% | +$0 | <0.0001 | |
Royal Bank of Canada | $1,000.00 | <0.01 | 517 | +235.71% | +$702.13 | <0.0001 | |
U.S. Bancorp | $939.00 | <0.01 | 410 | +66.67% | +$375.60 | <0.0001 | |
Bank of America | $916.00 | <0.01 | 400 | -2.2% | -$20.61 | <0.0001 | |
JPMorgan Chase | $671.00 | <0.01 | 293 | 0% | +$0 | <0.0001 | |
Wells Fargo | $612.00 | <0.01 | 267 | -16.56% | -$121.48 | <0.0001 | |
Huntington National Bank | $275.00 | <0.01 | 120 | 0% | +$0 | <0.0001 | |
RhumbLine Advisers | $320.00 | <0.01 | 140 | 0% | +$0 | <0.0001 | |
GENWORTH FINANCIAL WEALTH MANAGEMENT INC | $2.00 | <0.01 | 1 | New | +$2.00 | <0.0001 | |
Guardian Wealth Management Inc | $5.00 | <0.01 | 2 | 0% | +$0 | <0.0001 | |
Aspire Private Capital | $2.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
Old Point Trust & Financial Service | $115.00 | <0.01 | 50 | New | +$115.00 | <0.0001 | |
Qube Research & Technologies | $5.00 | <0.01 | 2 | 0% | +$0 | <0.0001 |